B062 Leronlimab is associated with long‑term survival in metastatic TNBC: Enhancing PD-L1 expression, ICI response, and modulates T cell exhaustion. Richard Pestell. Pennsylvania Cancer and Regenerative Medicine Research Center, Baruch S. Blumberg Institute, Wynnewood, PA, United States.
https://www.aacr.org/wp-content/uploads/2026/...ESONLY.pdf